287 related articles for article (PubMed ID: 16490236)
1. Surgical resection of recurrent endometrial carcinoma.
Awtrey CS; Cadungog MG; Leitao MM; Alektiar KM; Aghajanian C; Hummer AJ; Barakat RR; Chi DS
Gynecol Oncol; 2006 Sep; 102(3):480-8. PubMed ID: 16490236
[TBL] [Abstract][Full Text] [Related]
2. Surgical treatment of recurrent endometrial carcinoma.
Campagnutta E; Giorda G; De Piero G; Sopracordevole F; Visentin MC; Martella L; Scarabelli C
Cancer; 2004 Jan; 100(1):89-96. PubMed ID: 14692028
[TBL] [Abstract][Full Text] [Related]
3. Maximal cytoreductive surgery as a reasonable therapeutic alternative for recurrent endometrial carcinoma.
Scarabelli C; Campagnutta E; Giorda G; DePiero G; Sopracordevole F; Quaranta M; DeMarco L
Gynecol Oncol; 1998 Jul; 70(1):90-3. PubMed ID: 9698481
[TBL] [Abstract][Full Text] [Related]
4. Salvage cytoreductive surgery for recurrent endometrial cancer.
Bristow RE; Santillan A; Zahurak ML; Gardner GJ; Giuntoli RL; Armstrong DK
Gynecol Oncol; 2006 Oct; 103(1):281-7. PubMed ID: 16631236
[TBL] [Abstract][Full Text] [Related]
5. Stage IVB endometrial carcinoma: the role of cytoreductive surgery and determinants of survival.
Bristow RE; Zerbe MJ; Rosenshein NB; Grumbine FC; Montz FJ
Gynecol Oncol; 2000 Aug; 78(2):85-91. PubMed ID: 10926785
[TBL] [Abstract][Full Text] [Related]
6. Pelvic exenteration for recurrent endometrial cancer.
Barakat RR; Goldman NA; Patel DA; Venkatraman ES; Curtin JP
Gynecol Oncol; 1999 Oct; 75(1):99-102. PubMed ID: 10502433
[TBL] [Abstract][Full Text] [Related]
7. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.
Landrum LM; Moore KN; Myers TK; Lanneau GS; McMeekin DS; Walker JL; Gold MA
Gynecol Oncol; 2009 Feb; 112(2):337-41. PubMed ID: 19041126
[TBL] [Abstract][Full Text] [Related]
8. Complete surgical cytoreduction of advanced ovarian carcinoma using the argon beam coagulator.
Bristow RE; Montz FJ
Gynecol Oncol; 2001 Oct; 83(1):39-48. PubMed ID: 11585412
[TBL] [Abstract][Full Text] [Related]
9. Impact of secondary cytoreductive surgery on survival of patients with advanced epithelial ovarian cancer.
Zang RY; Zhang ZY; Li ZT; Cai SM; Tang MQ; Chen J; Liu Q
Eur J Surg Oncol; 2000 Dec; 26(8):798-804. PubMed ID: 11087649
[TBL] [Abstract][Full Text] [Related]
10. [Factors affecting disease recurrence and the role of secondary therapies in the management for patients with recurrent ovarian carcinoma].
Zang R; Zhang Z; Cai S
Zhonghua Fu Chan Ke Za Zhi; 2002 Sep; 37(9):546-9. PubMed ID: 12411017
[TBL] [Abstract][Full Text] [Related]
11. Treatment of recurrent adenocarcinoma of the endometrium with pelvic exenteration.
Morris M; Alvarez RD; Kinney WK; Wilson TO
Gynecol Oncol; 1996 Feb; 60(2):288-91. PubMed ID: 8631553
[TBL] [Abstract][Full Text] [Related]
12. Radical pelvic resection and intraoperative radiation therapy for recurrent endometrial cancer: technique and analysis of outcomes.
Dowdy SC; Mariani A; Cliby WA; Haddock MG; Petersen IA; Sim FH; Podratz KC
Gynecol Oncol; 2006 May; 101(2):280-6. PubMed ID: 16321431
[TBL] [Abstract][Full Text] [Related]
13. Cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma.
Tebes SJ; Sayer RA; Palmer JM; Tebes CC; Martino MA; Hoffman MS
Gynecol Oncol; 2007 Sep; 106(3):482-7. PubMed ID: 17590420
[TBL] [Abstract][Full Text] [Related]
14. Tertiary cytoreduction in patients with recurrent ovarian carcinoma.
Leitao MM; Kardos S; Barakat RR; Chi DS
Gynecol Oncol; 2004 Oct; 95(1):181-8. PubMed ID: 15385129
[TBL] [Abstract][Full Text] [Related]
15. Secondary cytoreductive surgery for localized, recurrent epithelial ovarian cancer: analysis of prognostic factors and survival outcome.
Salani R; Santillan A; Zahurak ML; Giuntoli RL; Gardner GJ; Armstrong DK; Bristow RE
Cancer; 2007 Feb; 109(4):685-91. PubMed ID: 17219441
[TBL] [Abstract][Full Text] [Related]
16. Pelvic exenteration affords safe and durable treatment for locally advanced rectal carcinoma.
Gannon CJ; Zager JS; Chang GJ; Feig BW; Wood CG; Skibber JM; Rodriguez-Bigas MA
Ann Surg Oncol; 2007 Jun; 14(6):1870-7. PubMed ID: 17406945
[TBL] [Abstract][Full Text] [Related]
17. Recurrent micropapillary serous ovarian carcinoma.
Bristow RE; Gossett DR; Shook DR; Zahurak ML; Tomacruz RS; Armstrong DK; Montz FJ
Cancer; 2002 Aug; 95(4):791-800. PubMed ID: 12209723
[TBL] [Abstract][Full Text] [Related]
18. Operative salvage for locoregional recurrent colon cancer after curative resection: an analysis of 100 cases.
Bowne WB; Lee B; Wong WD; Ben-Porat L; Shia J; Cohen AM; Enker WE; Guillem JG; Paty PB; Weiser MR
Dis Colon Rectum; 2005 May; 48(5):897-909. PubMed ID: 15785892
[TBL] [Abstract][Full Text] [Related]
19. The benefits of low anterior en bloc resection as part of cytoreductive surgery for advanced primary and recurrent epithelial ovarian cancer patients outweigh morbidity concerns.
Park JY; Seo SS; Kang S; Lee KB; Lim SY; Choi HS; Park SY
Gynecol Oncol; 2006 Dec; 103(3):977-84. PubMed ID: 16837030
[TBL] [Abstract][Full Text] [Related]
20. Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma.
Chi DS; McCaughty K; Diaz JP; Huh J; Schwabenbauer S; Hummer AJ; Venkatraman ES; Aghajanian C; Sonoda Y; Abu-Rustum NR; Barakat RR
Cancer; 2006 May; 106(9):1933-9. PubMed ID: 16572412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]